FACTX
Price
$56.44
Change
-$0.01 (-0.02%)
Updated
Nov 18 closing price
Net Assets
3.3B
FSPHX
Price
$30.27
Change
+$0.15 (+0.50%)
Updated
Nov 19 closing price
Net Assets
6.22B
Interact to see
Advertisement

FACTX vs FSPHX

Header iconFACTX vs FSPHX Comparison
Open Charts FACTX vs FSPHXBanner chart's image
Fidelity Advisor Health Care M
Price$56.44
Change-$0.01 (-0.02%)
VolumeN/A
Net Assets3.3B
Fidelity Select Health Care
Price$30.27
Change+$0.15 (+0.50%)
VolumeN/A
Net Assets6.22B
FACTX vs FSPHX Comparison Chart in %
View a ticker or compare two or three
VS
FACTX vs. FSPHX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FACTX is a Hold and FSPHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.22B vs. FACTX (3.3B). FSPHX pays higher dividends than FACTX: FSPHX (0.02) vs FACTX (0.00). FACTX was incepted earlier than FSPHX: FACTX (29 years) vs FSPHX (44 years). FACTX (1.18) is less costly to investors than FSPHX (0.63). FACTX is a more actively managed with annual turnover of: 52.00 vs. FSPHX (40.00). FACTX (0) and FSPHX (0) have matching initial minimum investment requirements. FSPHX annual gain was more profitable for investors over the last year : 0.02 vs. FACTX (-3.32). FACTX return over 5 years is better than : -6.10 vs. FSPHX (-8.84).
FACTXFSPHXFACTX / FSPHX
Total Expense Ratio1.180.63187%
Annual Report Gross Expense Ratio1.180.63187%
Fund Existence29 years44 years-
Gain YTD12.79010.532121%
Front Load4%N/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets3.3B6.22B53%
Annual Yield % from dividends0.000.02-
Returns for 1 year-3.320.02-19,658%
Returns for 3 years7.9810.4776%
Returns for 5 years-6.10-8.8469%
Returns for 10 years59.7639.34152%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CVTCX55.320.24
+0.44%
Calamos Growth & Income C
PEMGX42.33N/A
N/A
Principal MidCap A
BRUFX564.66N/A
N/A
Bruce
REMVX11.03N/A
N/A
RBC Emerging Markets Value Equity I
SPMHX8.48N/A
N/A
Invesco SteelPath MLP Alpha R5